159 related articles for article (PubMed ID: 31141109)
1. All-Cause and Cause-Specific Mortality Risks Associated With Alopecia Areata: A Korean Nationwide Population-Based Study.
Lee S; Lee YB; Kim BJ; Bae S; Lee WS
JAMA Dermatol; 2019 Aug; 155(8):922-928. PubMed ID: 31141109
[TBL] [Abstract][Full Text] [Related]
2. Autoimmune, Inflammatory, Atopic, Thyroid, and Psychiatric Outcomes of Offspring Born to Mothers With Alopecia Areata.
Lee JY; Ju HJ; Han JH; Lee JH; Bae JM; Lee WS; Lee S
JAMA Dermatol; 2023 Jul; 159(7):711-719. PubMed ID: 37223925
[TBL] [Abstract][Full Text] [Related]
3. Trends in Prevalence and Incidence of Alopecia Areata, Alopecia Totalis, and Alopecia Universalis Among Adults and Children in a US Employer-Sponsored Insured Population.
Mostaghimi A; Gao W; Ray M; Bartolome L; Wang T; Carley C; Done N; Swallow E
JAMA Dermatol; 2023 Apr; 159(4):411-418. PubMed ID: 36857069
[TBL] [Abstract][Full Text] [Related]
4. Validation of Case Identification for Alopecia Areata Using International Classification of Diseases Coding.
Lavian J; Li SJ; Lee EY; Bordone LA; Polubriaginof FCG; Christiano AM; Mostaghimi A
Int J Trichology; 2020; 12(5):234-237. PubMed ID: 33531746
[TBL] [Abstract][Full Text] [Related]
5. Treatment Patterns for Alopecia Areata in the US.
Lee H; Huang KP; Mostaghimi A; Choudhry NK
JAMA Dermatol; 2023 Nov; 159(11):1253-1257. PubMed ID: 37728940
[TBL] [Abstract][Full Text] [Related]
6. Hair Regrowth Outcomes of Contact Immunotherapy for Patients With Alopecia Areata: A Systematic Review and Meta-analysis.
Lee S; Kim BJ; Lee YB; Lee WS
JAMA Dermatol; 2018 Oct; 154(10):1145-1151. PubMed ID: 30073292
[TBL] [Abstract][Full Text] [Related]
7. The risk of alopecia areata and other related autoimmune diseases in patients with sleep disorders: a Korean population-based retrospective cohort study.
Seo HM; Kim TL; Kim JS
Sleep; 2018 Sep; 41(9):. PubMed ID: 29955877
[TBL] [Abstract][Full Text] [Related]
8. Overall and Racial and Ethnic Subgroup Prevalences of Alopecia Areata, Alopecia Totalis, and Alopecia Universalis.
Sy N; Mastacouris N; Strunk A; Garg A
JAMA Dermatol; 2023 Apr; 159(4):419-423. PubMed ID: 36857044
[TBL] [Abstract][Full Text] [Related]
9. Topographic Phenotypes of Alopecia Areata and Development of a Prognostic Prediction Model and Grading System: A Cluster Analysis.
Lee S; Kim BJ; Lee CH; Lee WS
JAMA Dermatol; 2019 May; 155(5):564-571. PubMed ID: 30916724
[TBL] [Abstract][Full Text] [Related]
10. Time-Dependent Risk of Acute Myocardial Infarction in Patients With Alopecia Areata in Korea.
Shin JW; Kang T; Lee JS; Kang MJ; Huh CH; Kim MS; Kim HJ; Ahn HS
JAMA Dermatol; 2020 Jul; 156(7):763-771. PubMed ID: 32401269
[TBL] [Abstract][Full Text] [Related]
11. Alopecia areata in children.
Ahmed I; Nasreen S; Bhatti R
J Coll Physicians Surg Pak; 2007 Oct; 17(10):587-90. PubMed ID: 17999846
[TBL] [Abstract][Full Text] [Related]
12. Association of All-Cause and Cause-Specific Mortality Risks With Pyoderma Gangrenosum.
Lee S; Lee JY; Ju HJ; Lee JH; Koh SB; Bae JM; Han JH
JAMA Dermatol; 2023 Feb; 159(2):151-159. PubMed ID: 36542392
[TBL] [Abstract][Full Text] [Related]
13. Interventions for alopecia areata.
Delamere FM; Sladden MM; Dobbins HM; Leonardi-Bee J
Cochrane Database Syst Rev; 2008 Apr; (2):CD004413. PubMed ID: 18425901
[TBL] [Abstract][Full Text] [Related]
14. Human papillomavirus symptomatic infection associated with increased risk of new-onset alopecia areata: A nationwide population-based cohort study.
Tu TY; Chang R; Lai JN; Tseng CC; Chen ML; Yip HT; Hung YM; Cheng-Chung Wei J
J Autoimmun; 2021 May; 119():102618. PubMed ID: 33714796
[TBL] [Abstract][Full Text] [Related]
15. Cyclosporine With and Without Systemic Corticosteroids in Treatment of Alopecia Areata: A Systematic Review.
Nowaczyk J; Makowska K; Rakowska A; Sikora M; Rudnicka L
Dermatol Ther (Heidelb); 2020 Jun; 10(3):387-399. PubMed ID: 32270396
[TBL] [Abstract][Full Text] [Related]
16. Alopecia areata and overt thyroid diseases: A nationwide population-based study.
Han TY; Lee JH; Noh TK; Choi MW; Yun JS; Lee KH; Bae JM
J Dermatol; 2018 Dec; 45(12):1411-1417. PubMed ID: 30222206
[TBL] [Abstract][Full Text] [Related]
17. Metabolic syndrome in patients with Alopecia Areata: A case-control study.
Abdollahimajd F; Niknezhad N; Bahreini N; Younespour S; Namazi N
Dermatol Ther; 2021 Jul; 34(4):e14979. PubMed ID: 33991033
[TBL] [Abstract][Full Text] [Related]
18. Epidemiology of alopecia areata, ophiasis, totalis, and universalis: A systematic review and meta-analysis.
Lee HH; Gwillim E; Patel KR; Hua T; Rastogi S; Ibler E; Silverberg JI
J Am Acad Dermatol; 2020 Mar; 82(3):675-682. PubMed ID: 31437543
[TBL] [Abstract][Full Text] [Related]
19. Factors Associated with Severity of Alopecia Areata.
You HR; Kim SJ
Ann Dermatol; 2017 Oct; 29(5):565-570. PubMed ID: 28966512
[TBL] [Abstract][Full Text] [Related]
20. Risks of alopecia areata in long COVID: Binational population-based cohort studies from South Korea and Japan.
Kyung S; Son Y; Kim M; Kang J; Smith L; Lee H; Yon DK
J Med Virol; 2024 May; 96(5):e29668. PubMed ID: 38757870
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
